HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1959414Generated: November 2, 2026
1-(2-(Methylsulfonyl)ethyl)piperazine → tert-butyl N-tert-butoxylcarbonyl-5-(4-(2-(methylsulfonyl)ethyl)piperazin-1-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-ylcarbamate
https://huagongshe.com/reaction/1959414
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 1-(2-(Methylsulfonyl)ethyl)piperazine | HCID 3801959 | — |
| Reactant | Tert-butyl N-[5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-N-tert-butoxycarbonyl-carbamate | HCID 59471994 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | tert-butyl N-tert-butoxylcarbonyl-5-(4-(2-(methylsulfonyl)ethyl)piperazin-1-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-ylcarbamate | HCID 66745771 | 100% |
Reaction Steps
tert-butyl N-tert butoxycarbonyl-5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-ylcarbamate (75 mg, 0.13 mmol) was dissolved in DMF (1 mL) and 1-(2-(methylsulfonyl)ethyl)piperazine (77 mg, 0.40 mmol) was added. The reaction mixture was heated at 100° C. in a sealed tube overnight. The reaction mixture was cooled to room temperature and partitioned between CH2Cl2 and water and the layers separated using a phase separation cartridge. The organic layer was concentrated in vacuo to give the product (84.01 mg, 0.13 mmol)
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08410112B2 |
|---|
| Source dataset | uspto-grants-2013_04 |
|---|
| ORD ID | ord-3fd441451b424e0bb940a70424ffa81d |
|---|
| Source note | uspto-grants-2013_04 |
|---|